The program remains a critical funding source for safety-net hospitals and the patients they serve
April 16, 2025: Parties in Trulicity Lawsuit to Hold Hearing on Gastroparesis On May 14, 2025, the parties involved in the Trulicity multidistrict litigation will hold a hearing about the reliable diagnostic process for gastroparesis
[1] [2] It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists , which work by mimicking the action of a naturally occurring hormone that helps regulate blood sugar levels
D.AnckarJ.StevensS
Organizations are balancing the ongoing demand from employees for GLP-1 coverage for weight loss by continuing to explore feasibility through cost-control mechanisms. Cost-Control Mechanisms Of those covering GLP-1 drugs, employers are using eligibility requirements (45%) and an annual maximum (32%) as cost-control mechanisms
While there is no clear timeline for when the drug will be listed, once it is, the price will be dramatically slashed for eligible patients
.webp)
